ide161
ideaya biosciences
['ide161', 'ovarian', 'breast', '$idya']
$idya abstract 6093: "ide161, a potential first-in-class clinical candidate parg inhibitor, selectively targets homologous-recombination-deficient and parp inhibitor resistant breast and ovarian tumors" 
L/S Equity
Bio/Rare Focus + Tactical

I read a filing or 2 ;)

This is not financial advice.